SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TATRADER who wrote (424)9/8/1996 9:22:00 AM
From: Richard Mazzarella   of 4342
 
Mark, I don't want to take up PRLN space talking about another biotech, but maybe a discussion will instructive. I clearly don't have all the answers, but after spending a little time looking at VMRX I have some opinions. All stocks not in Chapter 11 are "good stories". Yes VMRX is a "chart technical" trading play, but they are a "johnny 2 (maybe 3) note" that would get killed if their trials go south. Their main HIV drug is very toxic compared to PRLN. PRLN is a multidimential company where their strength is their signal transduction technology, not a couple of drugs. The VMRX HepC product looks interesting, but could easily get easily displaced by others. The cancer drug is too far out. Maybe I am reading VMRX wrong? PRLN has a concept very different than the typical druggies, TCM. That is what intrigues me about them. I know that I said that biotechs are just trading plays and I violate my own rules on investing by "loving" PRLN. It may be a money stupid thing to do, but I feel much safer owning PRLN than I would VMRX, chart play or not. Mark, I sure would like to hear your opinion on PRLN. I don't know of any "Masters" here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext